132 related articles for article (PubMed ID: 8915680)
1. Heterogeneity of drug susceptibility of mouse active anaphylactic shock.
Kimura S; Watanabe A; Nagata M; Niinomi Y; Harada M
Immunol Invest; 1996; 25(5-6):425-34. PubMed ID: 8915680
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Harada M
Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
Arimura A; Harada M
Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
[TBL] [Abstract][Full Text] [Related]
4. Drug susceptibility of PCA in WBB6F1-W/Wv mice.
Kimura S; Watanabe A; Takeuchi M; Nagata M; Nakamura K; Harada M
Cell Mol Life Sci; 1998 May; 54(5):456-60. PubMed ID: 9645225
[TBL] [Abstract][Full Text] [Related]
5. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Watanabe A; Nakamura K; Takeuchi M; Harada M
Experientia; 1990 Jul; 46(7):739-42. PubMed ID: 2373200
[TBL] [Abstract][Full Text] [Related]
6. Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice.
Kimura S; Nagata M; Takeuchi M; Takano K; Harada M
Cell Mol Life Sci; 1997 Aug; 53(8):663-6. PubMed ID: 9351469
[TBL] [Abstract][Full Text] [Related]
7. Antigen-induced anaphylactic death in mice.
Lei HY; Lee SH; Leir SH
Int Arch Allergy Immunol; 1996 Apr; 109(4):407-12. PubMed ID: 8634527
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis or so-called encephalopathy in mice sensitized to an antigen with the aid of pertussigen (pertussis toxin).
Munoz JJ; Peacock MG; Hadlow WJ
Infect Immun; 1987 Apr; 55(4):1004-8. PubMed ID: 3557617
[TBL] [Abstract][Full Text] [Related]
9. High susceptibility of cataract Shionogi (CTS) mice to passive anaphylactic shock mediated by allogeneic IgE and IgG1 monoclonal antibodies.
Harada M; Nagata M; Takeuchi M; Makino S; Aburahi S
Immunol Invest; 1991 Jun; 20(3):305-15. PubMed ID: 1874560
[TBL] [Abstract][Full Text] [Related]
10. Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Wang M; Shibamoto T; Tanida M; Kuda Y; Kurata Y
Life Sci; 2014 Oct; 116(2):98-105. PubMed ID: 25252221
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent difference in susceptibility to IgE antibody- and IgG1 antibody-mediated passive anaphylactic shock in the mouse.
Harada M; Nagata M; Takeuchi M; Ohara T; Makino S; Watanabe A
Immunol Invest; 1991; 20(5-6):515-23. PubMed ID: 1791039
[TBL] [Abstract][Full Text] [Related]
12. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
13. A lethal role of platelet activating factor in anaphylactic shock in mice.
Terashita Z; Imura Y; Shino A; Nishikawa K
J Pharmacol Exp Ther; 1987 Oct; 243(1):378-83. PubMed ID: 3118009
[TBL] [Abstract][Full Text] [Related]
14. [Antigenicity studies of prulifloxacin (NM441)].
Tateda C; Sakai K; Yamakawa S; Nakasuji T; Nakamura T; Sumi N; Shindo Y
J Toxicol Sci; 1996 Jun; 21 Suppl 1():231-9. PubMed ID: 8709164
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
16. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
Arimura A; Nagata M; Takeuchi M; Watanabe A; Nakamura K; Harada M
Immunol Invest; 1990 Jun; 19(3):227-33. PubMed ID: 2365426
[TBL] [Abstract][Full Text] [Related]
17. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Wang M; Shibamoto T; Kuda Y; Tanida M; Zhang T; Song J; Kurata Y
Life Sci; 2016 Feb; 147():77-84. PubMed ID: 26808090
[TBL] [Abstract][Full Text] [Related]
18. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.
Arias K; Baig M; Colangelo M; Chu D; Walker T; Goncharova S; Coyle A; Vadas P; Waserman S; Jordana M
J Allergy Clin Immunol; 2009 Aug; 124(2):307-14, 314.e1-2. PubMed ID: 19409603
[TBL] [Abstract][Full Text] [Related]
19. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
Waxman FJ; Taguiam JM; Whitacre CC
Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice.
Choi IH; Shin YM; Park JS; Lee MS; Han EH; Chai OH; Im SY; Ha TY; Lee HK
J Exp Med; 1998 Nov; 188(9):1587-92. PubMed ID: 9802970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
